Alnylam Pharmaceuticals Sponsored Study Titled ‘Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program’ Posted To ClinicalTrials.gov; Study Is Recruiting
https://clinicaltrials.gov/ct2/show/NCT05040373
BMO Capital Maintains Market Perform on Alnylam Pharmaceuticals, Raises Price Target to $196
BMO Capital analyst Gary Nachman maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Market Perform and raises the price target from $174 to $196.
This Robot-Run Large Cap ETF Has Less Apple, Microsoft, Amazon, Facebook Compared To SPY And Is Bullish On These Manufacturing Stocks Instead
The Qraft AI-Enhanced US Large Cap ETF (NYSE: QRFT) has revealed that it has less holdings in “big tech” companies such as Microsoft Corp.
HC Wainwright & Co. Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $250
HC Wainwright & Co. analyst Patrick Trucchio maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $235 to $250.
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 11)
Stocks That Hit 52-Week Highs On Wednesday
During the morning session on Wednesday, 125 stocks hit new 52-week highs.
The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 10)
Analyzing Alnylam Pharmaceuticals’s Unusual Options Activity
On Tuesday, shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) saw unusual options activity. After the option alert, the stock price moved up to $201.39.
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs.
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 9)